Results 191 to 200 of about 34,840,596 (291)

Correction to: A Risk-Based Approach for Safety Case Follow-up of Adverse Event Reports in Pharmacovigilance. [PDF]

Adv Ther
Vemula GK, Badale P, Mavrogenis P, Lalande-Luesink I, Borkowski M, Lewis DJ.   +5 more
europepmc   +1 more source

The RABBIT risk-based approach to clinical implementation of new technology: SRS as a case study. [PDF]

Tech Innov Patient Support Radiat Oncol, 2020
Ralston A, Graham P, Poder J, Yuen J.
europepmc   +1 more source

Exploring the influence of lactoferrin on wound healing and related signaling pathways: a systematic review

FEBS Open Bio, EarlyView.
Lactoferrin promotes wound healing by activating MAPK, PI3K/Akt, and extracellular matrix pathways, enhancing fibroblast remodeling, proliferation, and re‐epithelialization. These mechanisms highlight its therapeutic potential in inflammation control, tissue repair, and remodeling.
Morgana Lüdtke Azevedo, Kátia Cristiane Hall, Matheus dos Santos Fernandez, Geovanna Peter Corrêa, Rafael Guerra Lund   +4 more
wiley   +1 more source

Management of fetuses with apparent normal growth and abnormal cerebroplacental ratio: A risk-based approach near term. [PDF]

Acta Obstet Gynecol Scand
Morales-Roselló J, Khalil A, Martínez-Varea A.   +2 more
europepmc   +1 more source

Accurate and noninvasive prostate cancer detection using plasma‐derived extracellular vesicle RNA

FEBS Open Bio, EarlyView.
Plasma extracellular vesicles were captured with WGA‐conjugated magnetic beads and profiled for RNA biomarkers. A three‐RNA panel (NM_024955, NR_047469, and NR_002564) distinguished prostate cancer from healthy controls and benign prostatic hyperplasia, supporting a simple, noninvasive approach to improve prostate cancer detection.
Hanping Wei, Haoran Wu, Wei Feng
wiley   +1 more source

Abstract Versus Concrete Risk Identification in Clinical Research in Japan: Randomized and Prospective Pilot Research on the Effect of Risk Reduction Activities in a Risk-Based Approach. [PDF]

Ther Innov Regul Sci
Kondo H, Chiu SW, Hayashi Y, Takahashi N, Yamaguchi T.   +4 more
europepmc   +1 more source

A risk-based approach to experimental early phase clinical trials during the COVID-19 pandemic. [PDF]

Lancet Oncol, 2020
Tiu C, Shinde R, Yap C, Rao Baikady B, Banerji U, Minchom AR, de Bono JS, Lopez JS.   +7 more
europepmc   +1 more source

In silico and in vitro exploration of a tyrosinase for biocatalytic production of catechols

FEBS Open Bio, EarlyView.
Tyrosinase from Ralstonia pseudosolanacearum is a promising biocatalyst for producing valuable catechols from monophenol substrates. This tyrosinase is uniquely suited to this due to its high monophenolase : diphenolase ratio. We combined in silico docking and in vivo kinetic characterisation of this tyrosinase with 11 industrially relevant monophenols,
James Britton, Fang Zhao, Reeta Davis, Meg Walsh, Kevin E O'Connor, David O'Connell, Tanja Narancic   +6 more
wiley   +1 more source

A Risk-Based Approach for Safety Case Follow-up of Adverse Event Reports in Pharmacovigilance. [PDF]

Adv Ther
Vemula GK, Badale P, Mavrogenis P, Lalande-Luesink I, Borkowski M, Lewis DJ.   +5 more
europepmc   +1 more source

Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach. [PDF]

Ann Intern Med, 2020
Clase CM, Fu EL, Joseph M, Beale RCL, Dolovich MB, Jardine M, Mann JFE, Pecoits-Filho R, Winkelmayer WC, Carrero JJ.   +9 more
europepmc   +1 more source